Betamethasone Dipropionate 0.05% Cream

DRUG2 trials

Sponsors

Padagis LLC, MC2 Therapeutics

Conditions

HealthyVasoconstriction

Phase 1

Evaluation of the Vasoconstriction Properties of MC2-01 Cream

CompletedNCT03758365

MC2 TherapeuticsVasoconstriction

Start: 2018-11-05End: 2018-11-23Updated: 2020-01-09

Unknown Phase

Randomized Study to Compare the Bioavailability of Two Augmented Betamethasone Dipropionate 0.05% Topical Creams

CompletedNCT00800293

Padagis LLCHealthy

Start: 2002-12-31End: 2003-01-31Updated: 2021-10-18